An-Najah National University

Dr. Hamzeh M. ALZABADI

 

 
  • Bookmark and Share Email
     
  • Tuesday, February 11, 2014
  • Short-term outcomes of laparoscopic sleeve gastrectomy among obesity patients in the northern west bank: a retrospective records review
  • Published at:BMC Research Notes 2014, 7:85 doi:10.1186/1756-0500-7-85
  • Background

    Conservative methods for weight loss are usually disappointing. Therefore, surgeries such as Laparoscopic Sleeve Gastrectomy (LSG) should be considered. We aimed to evaluate the outcomes (body mass index; BMI) of LSG among obesity patients in the Northern West Bank.

    Methods

    Hospital records were reviewed for all patients who had undergone LSG since 2010 in Arab specialized hospital in Nablus and Palestinian Red Crescent society hospital in Tulkarem. Then, patients have been invited again to participate in the study and asked to self-report further pre-/post-operative measures. The primary study outcome was the change in BMI while secondary outcomes included obesity associated co-morbidities’ measures; hypertension (HTN) and diabetes mellitus (DM).

    Results

    The mean age (standard deviation; SD) of the study participants (n = 30; 20 women and 10 men) was 34.06 (10.71) years. The mean (SD) follow-up time was 7.16 (5.05) months. The mean ± SD of the pre-operative BMI was 47.23 ± 7.89 kg/m2 while 36.74 ± 7.74 kg/m2 post-operatively (95% CI for mean differences and P-value; 8.83-12.14 and 0.001). For the clinically diagnosed hypertensive patients, there was a mean (SD) reduction of 27.50 (9.87) mm Hg in systolic pressure (P < 0.026) and 18.33 (13.66) of the diastolic blood pressure (P < 0.042). For diabetics, there were clinically and biologically clear mean (SD) reductions in fasting blood sugar and glycated hemoglobin A1c of about 82.00 (22.70) mg/dl and 1.90 (0.78) %; respectively. Only practicing sports or exercise (no/yes) remained significant with post-operative BMI (regression coefficient B = −7.33; P-value and 95% CI for B; 0.009 and −12.68- -1.98).

    Conclusions

    LSG can significantly improve BMI and could improve or resolve obesity associated co-morbidities like HTN and DM. LSG could be recommended for co-morbid obesity patients who fail to reach beneficial results from a structured weight loss programs.

     
  • Bookmark and Share Email
     
Leave a Comment

Attachments

  • No Attachments Found for this Article

PROFILE

Hamzeh M. ALZABADI; BSc, MPH, PhD
Health and Life Sciences
 
Show Full ProfileEnglish CV
 
 
 
Please do not email me if you do not know me
Please do not e-mail me if you do not know me